Mark Connolly

Managing Director at Global Market Access Solutions
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Lausanne, Vaud, Switzerland, CH

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Managing Director
      • Feb 2008 - Present

      Global Market Access Solutions is a pricing and market access consultancy providing services to pharmaceutical and medical technology firms. We specialise in a range of quantitative and qualitative approaches to define product value. Specific approaches include economic evaluation, budget impact analysis, Delphi techniques, multi-criteria decision analysis (MCDA) and value based pricing used to support pricing and reimbursement.We are also engaged in developing carbon certification methodologies for healthcare programs and technologies that can influence future carbon emissions. These methodologies enable firms to link technologies to reduced carbon emissions and certification of these emission reductions for trading on carbon markets.

    • Netherlands
    • Research Services
    • 700 & Above Employee
    • Senior Research Scientist
      • Oct 2008 - Present

      We have developed a fiscal health modelling framework that investigates how changes in health impact on government public accounts. Specifically the fiscal health model quantifies how changes in health impact on government tax revenue and transfer costs (eg, social insurances, disability, health costs, etc). The framework can be used to conduct policy analysis using cost-benefit analysis from government perspective. We have developed a fiscal health modelling framework that investigates how changes in health impact on government public accounts. Specifically the fiscal health model quantifies how changes in health impact on government tax revenue and transfer costs (eg, social insurances, disability, health costs, etc). The framework can be used to conduct policy analysis using cost-benefit analysis from government perspective.

    • United States
    • Environmental Services
    • 1 - 100 Employee
    • Advisor
      • Jan 2017 - Present

      We are engaged in developing carbon certification methodologies for healthcare programs and technologies that can influence future carbon emissions. These methodologies enable firms to link technologies to reduced carbon emissions and certification of these emission reductions for trading on carbon markets. We are engaged in developing carbon certification methodologies for healthcare programs and technologies that can influence future carbon emissions. These methodologies enable firms to link technologies to reduced carbon emissions and certification of these emission reductions for trading on carbon markets.

    • Director Market Access & Pricing
      • May 2005 - Jan 2008

      Great place to workwww.ferring.com Great place to workwww.ferring.com

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Health Outcomes Manager
      • Jun 2003 - Apr 2005

    • France
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Health Economics Project Manager
      • Nov 2000 - May 2003

      Based in Sydney Australia Based in Sydney Australia

    • United States
    • Research Services
    • 700 & Above Employee
    • Health Economics Associate
      • Apr 1999 - Nov 2000

      CRO, I worked in the health economics consulting group. CRO, I worked in the health economics consulting group.

    • Research Scientist
      • Dec 1997 - Mar 1999

    • Australia
    • Research
    • 100 - 200 Employee
    • Research Associate
      • Dec 1994 - Jan 1997

      Drug-receptor interaction, cell biology Drug-receptor interaction, cell biology

    • Armed Forces
    • 700 & Above Employee
    • Rescue Boat Captain
      • Mar 1984 - Apr 1988

Education

  • University of Groningen
    Ph.D., Health Economics
    2009 - 2010
  • University of Michigan
    MSc, Pharmacology
    1992 - 1994
  • University of Geneva
    MDC, Development Economics and International Development
    2006 - 2007
  • Curtin University
    M.H.E, Health Economics
    2000 - 2003
  • University of Sydney
    Grad Dip, Health Economics
    2001 - 2002
  • University of Toledo
    BA, Biology
    1988 - 1992

Community

You need to have a working account to view this content. Click here to join now